Advisors Asset Management, Inc. United Therapeutics Corp Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 4,787 shares of UTHR stock, worth $1.66 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,787

Previous 4,983 3.93%

Holding current value

$1.66 Million

Previous $1.59 Million 8.07%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$311.04 - $363.55 $60,963 - $71,255	-196 Reduced 3.93%	4,787 $1.72 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $34,010 - $47,536	-149 Reduced 2.9%	4,983 $1.59 Million
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $383,372 - $453,858	-1,819 Reduced 26.17%	5,132 $1.18 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $161,804 - $193,475	-753 Reduced 9.77%	6,951 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $23,802 - $27,026	-116 Reduced 1.48%	7,704 $1.7 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $312,669 - $405,417	1,468 Added 23.11%	7,820 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $948,399 - $1.29 Million	4,605 Added 263.59%	6,352 $1.77 Million
Q3 2022 Nov 08, 2022	SELL	$203.3 - $244.17 $46,352 - $55,670	-228 Reduced 11.54%	1,747 $366,000
Q2 2022 Aug 08, 2022	SELL	$174.81 - $241.14 $211,869 - $292,261	-1,212 Reduced 38.03%	1,975 $465,000
Q1 2022 May 17, 2022	SELL	$166.16 - $213.96 $3,655 - $4,707	-22 Reduced 0.69%	3,187 $572,000
Q4 2021 Feb 15, 2022	BUY	$184.32 - $216.08 $69,120 - $81,030	375 Added 13.23%	3,209 $693,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $65,109 - $77,786	362 Added 14.64%	2,834 $523,000
Q2 2021 Jul 30, 2021	BUY	$170.47 - $211.93 $131,943 - $164,033	774 Added 45.58%	2,472 $444,000
Q1 2021 May 07, 2021	SELL	$153.94 - $174.85 $6,619 - $7,518	-43 Reduced 2.47%	1,698 $284,000
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $13,039 - $19,429	128 Added 7.94%	1,741 $264,000
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $74,625 - $90,484	747 Added 86.26%	1,613 $163,000
Q2 2020 Aug 12, 2020	BUY	$92.74 - $125.82 $79,756 - $108,205	860 Added 14333.33%	866 $105,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $63,754 - $75,469	-595 Reduced 99.0%	6 $1,000
Q4 2018 Jan 31, 2019	SELL	$101.4 - $128.73 $10,444 - $13,259	-103 Reduced 14.63%	601 $65,000
Q3 2018 Nov 15, 2018	SELL	$113.81 - $129.46 $172,080 - $195,743	-1,512 Reduced 68.23%	704 $90,000
Q2 2018 Aug 15, 2018	SELL	$101.14 - $118.31 $26,397 - $30,878	-261 Reduced 10.54%	2,216 $251,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $12,543 - $17,776	-117 Reduced 4.51%	2,477 $287,000
Q4 2017 Feb 13, 2018	SELL	$118.58 - $151.28 $12,213 - $15,581	-103 Reduced 3.82%	2,594 $384,000
Q3 2017 Nov 07, 2017	BUY	$114.6 - $136.81 $309,076 - $368,976	2,697	2,697 $316,000

Others Institutions Holding UTHR

# of Institutions

692

Shares Held

60.6M

Call Options Held

194K

Put Options Held

298K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $15.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. United Therapeutics Corp Transaction History